A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Walking lunges are a dynamic version of regular lunges. Instead of stepping forward and returning to the starting point, this ...

Drugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

The new weight loss drug which is set to give Ozempic and Mounjaro a run for their money, MariTide, is taken on a monthly ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Once-weekly amycretin, a novel peptide activating GLP-1, amylin, and calcitonin receptors, produced rapid, substantial, and ...

Thousands are now eligible to get Mounjaro through the NHS, but some may need to avoid it and it might not even work for others ...